Dewey Sedman | Head-Investor Relations |
Martine Rothblatt | Chairperson and Chief Executive Officer |
Michael Benkowitz | President and Chief Operating Officer |
Eun Yang | Jefferies |
Hartaj Singh | Oppenheimer & Company |
Terence Flynn | Morgan Stanley |
Joseph Thome | Cowen and Company |
Jessica Fye | JPMorgan |
Andreas Argyrides | Wedbush |
Good morning, and welcome to the United Therapeutics Corporation Third Quarter 2022 Earnings Webcast. My name is Chantel and I will be your conference operator today. All participants on the call portion of the webcast will be in a listen-only mode until the question-and-answer portion of this earnings call. [Operator Instructions] I will now turn the webcast over to Dewey Steadman, Head of Investor Relations at United Therapeutics.
Good morning.